# A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

> **NCT01740934** · NA · COMPLETED · sponsor: **Rock Creek Pharmaceuticals, Inc.** · enrollment: 117 (actual)

## Conditions studied

- Rosacea

## Interventions

- **OTHER:** Anatabloc Cream
- **OTHER:** Placebo Cream

## Key facts

- **NCT ID:** NCT01740934
- **Lead sponsor:** Rock Creek Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740934, "A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01740934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*